Wahana Interfood Nusantara
COCO
$54.76
-1.85%
The Vita Coco Company is a plant-based functional hydration platform whose core business is coconut water — sold under the flagship Vita Coco brand as well as through a sizable private-label coconut water and oil operation — supplemented by smaller brands such as Runa, Ever & Ever, and PWR LIFT, and product extensions into sparkling coconut water and coconut milk. The company is best characterized as the category leader and brand anchor in the fast-growing coconut water niche within the broader non-alcoholic beverages space, with a vertically integrated, asset-light model that sources from a global farmer network and distributes primarily through the U.S. and Canadian retail channel (the Americas segment, which generates the majority of revenue) plus an International segment spanning Europe, the Middle East, Africa, and Asia Pacific. The current investor narrative centers on a sharp growth reacceleration — first-quarter 2026 revenue rose roughly 37% year over year to about $180 million with gross margin expanding toward 40% — which has revived the bull case around brand pricing power, private-label mix, and international expansion after a volatile 2025 marked by a weak fourth quarter and margin pressure. Debate now hinges on whether this acceleration is durable or a shipment-timing and pricing artifact, particularly given the stock's violent swings over the past six months and a recent pullback from its highs despite the strong fundamental print.…
COCO
Wahana Interfood Nusantara
$54.76
Related headlines
Investment Opinion: Should I buy COCO Today?
Rating: Buy (accumulate on weakness). The core thesis is that COCO is a category-leading, debt-free functional-hydration brand whose Q1 2026 reacceleration (+37.3% revenue growth, 39.68% gross margin, 18.68% operating margin) is not yet reflected in a stock trading 14.3% below its three-month-ago level, with a consensus buy rating (mean 1.58) and a $79.10 average target implying ~40% upside. The recommendation is anchored to the analyst consensus and the gap between price and target, tempered by the need for Q2 confirmation.
Supporting evidence is strong across four dimensions. First, growth: Q1 2026 revenue of $179.8M rose 37.3% YoY versus a flat Q4 2025, and the consensus forward revenue estimate of $1.24B implies continued double-digit expansion. Second, profitability: gross margin expanded to 39.68% from 36.57%, operating margin to 18.68%, and net income to $30.5M from $18.9M. Third, balance sheet and cash: debt-to-equity of 0.0447, current ratio of 3.62, $203.2M cash, $64.5M trailing FCF, ROE of 21.5% and ROA of 16.5%. Fourth, valuation: forward PE of 25.0x is a ~41% discount to the 42.4x trailing multiple, PS of 4.95x is near the low end of its multi-year range, and the $3.09 consensus EPS estimate versus $56.53 price gives a PEG of 1.61x — a premium to staples but reasonable for 30%+ growth.
Three risks could invalidate the thesis: (1) Q1 growth proves to be restocking/pricing rather than velocity, with the $39.4M receivables build as a warning sign; (2) the 30.1x EV/EBITDA multiple compresses if growth decelerates below 20%; (3) gross margin reverts from 39.68% toward the 34.5% Q4 2025 level on private-label mix or input costs. The rating would upgrade to a stronger Buy if Q2 confirms 25%+ organic growth with gross margin above 39%, and would downgrade to Hold if revenue growth falls below 15% or gross margin drops under 36%. Verdict: fairly valued to modestly undervalued relative to its own history (low-end PS, mid-range forward PE) and cheap relative to its growth rate, but at a premium to staples peers — a growth stock priced for delivery, not a value bargain.
Sign up to view all
COCO 12-Month Price Forecast
The forward view is constructive but not high-conviction: the fundamental inflection is real and multi-dimensional, yet the stock's 14.3% three-month decline and -17.2 point relative strength versus SPY show the market has not yet endorsed the durability of the Q1 acceleration. Valuation is the swing factor — 25.0x forward earnings is defensible for 30%+ growth but rich against high-teens staples peers, and the 30.1x EV/EBITDA multiple assumes continued execution. The $39.4M receivables build is the key yellow flag that keeps confidence at medium rather than high. An upgrade to high confidence would come from Q2 confirming 25%+ organic growth with gross margin at or above 39.68%; a downgrade to neutral would follow any quarter with growth below 15% or gross margin under 36%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Wahana Interfood Nusantara's 12-month outlook, with a consensus price target around $79.10 and implied upside of +44.5% versus the current price.
Average Target
$79.10
0 analysts
Implied Upside
+44.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $90
Analyst target range
Coverage is solid with 10 analysts, and sentiment is decisively bullish: the consensus recommendation is "buy" with a mean rating of 1.58 (where 1.0 is a strong buy), and the average target price of $79.10 implies roughly +40% upside from the current $56.53. That is an unusually wide gap between price and target, indicating that the sell-side views the recent 14% three-month decline as an overreaction rather than a fundamental deterioration, and the consensus revenue estimate of $1.24 billion and EPS estimate of $3.09 for the forward period underpin that confidence.
The target range of $65.00 to $90.00 is wide — a 38% spread from low to high — which signals meaningful disagreement about the durability of the growth reacceleration. The high target of $90 assumes sustained 30%+ revenue growth, continued gross-margin expansion toward 40%+, and multiple support from international expansion and brand extensions; the low target of $65 still implies about +15% upside and likely assumes growth decelerates toward the high-teens with some margin normalization. Institutional ratings show a clear upgrade cycle — Stephens moved to Overweight in November 2025, BofA to Buy in November 2025, and Piper Sandler to Overweight in August 2025 — with no recent downgrades, reinforcing that the analyst community is leaning into the growth story even as the stock has pulled back.
Drowning in data?
Find the real signal!
Bulls vs Bears: COCO Investment Factors
The bull case currently has stronger evidence: the Q1 2026 print is concrete and multi-dimensional, with +37.3% revenue growth, gross margin up ~310bps YoY to 39.68%, operating margin at 18.68%, a debt-free balance sheet with $203.2M cash, and a sell-side consensus target of $79.10 implying ~40% upside. The bear case rests more on inference — that the acceleration may be shipment-timing and pricing rather than durable velocity — plus a 30.1x EV/EBITDA multiple that prices in continued execution. The single most important tension is whether Q1's +37% growth is real demand or a restocking artifact: if Q2 confirms organic velocity with gross margin holding near 40%, the premium multiple is justified and the stock re-rates toward analyst targets; if growth reverts toward the high-teens, the 30x EBITDA multiple compresses and the recent 14% three-month decline extends. Technicals currently favor patience over chasing, since the stock is in a lower-high/lower-low corrective phase below the $63.50-$65.00 resistance shelf.
Bullish
- Revenue reaccelerated to +37.3% YoY: Q1 2026 revenue hit $179.8M versus $130.9M in Q1 2025, a sharp inflection from Q4 2025's roughly flat $127.8M versus $127.3M. Branded Vita Coco Coconut Water contributed $140.6M of the total, showing the core brand, not just private label, is driving the acceleration.
- Margins expanded across the P&L: Gross margin rose to 39.68% in Q1 2026 from 36.57% a year earlier and 34.54% in Q4 2025, while operating margin reached 18.68% and EBITDA margin 21.09%. Net income of $30.5M (16.95% margin) more than offset the prior-year $18.9M, confirming operating leverage is real, not just gross-profit optics.
- Pristine balance sheet, self-funded growth: Debt-to-equity is just 0.0447 and the current ratio is 3.62, with $203.2M of cash against negligible debt. Q1 2026 free cash flow of $15.1M and $11.5M of buybacks show the company funds growth and returns capital internally.
- Analyst consensus implies ~40% upside: With 10 analysts, a mean rating of 1.58 (buy) and an average target of $79.10 versus the $56.53 price, the sell-side sees roughly +40% upside. The low target of $65 still implies ~+15%, and the upgrade cycle (Stephens, BofA, Piper Sandler) has seen no recent downgrades.
Bearish
- Growth durability is unproven: The swing from flat Q4 2025 revenue to +37.3% in Q1 2026 is the central question — it could reflect channel restocking and pricing rather than underlying velocity. Q1 also carried a $39.4M receivables build and a $17.4M working-capital drag, a pattern that can accompany shipment pull-forward.
- Premium multiple leaves no room for error: EV/EBITDA of 30.1x is roughly double typical beverage-sector mid-teens multiples, and P/B is 9.10x with a PEG of 1.61x. At 25.0x forward earnings versus high-teens to low-20s for staples peers, any growth deceleration would compress the multiple sharply.
- Technical structure is deteriorating: The stock is down 14.3% over three months and 2.5% over one month versus a +38.4% one-year gain, with 3-month relative strength of -17.2 points against SPY. It sits only ~37% up its $39.60-$85.83 range and fell 4.19% on the latest session after a failed spike to $63.50.
- Earnings history is volatile and lumpy: Q4 2025 net income was just $5.5M (4.3% margin) and Q4 2024 was $3.4M (2.7% margin), showing the business can swing to near-breakeven profitability in weak quarters. Trailing EPS of about $0.024 makes the 42.4x trailing PE largely meaningless and highlights earnings instability.
COCO Technical Analysis
COCO is in a recovery-then-rollover pattern rather than a clean uptrend: the stock is up 38.4% over the trailing year, but that gain masks a peak-to-trough drawdown of -39.7% and a current price of $56.53 that sits only about 37% of the way up its 52-week range of $39.60 to $85.83. In other words, the stock is trading in the lower-middle third of its annual band — closer to the low than the high — which signals that the powerful rally that carried shares from the low-$50s in April to above $84 in mid-June has been substantially unwound, leaving the stock in a corrective phase rather than at momentum-driven highs. The 1-year relative strength versus SPY of +25.3 percentage points confirms COCO has still outperformed the market over twelve months, but the positioning within the range argues against chasing strength and favors patience for a base to form.
Short-term momentum is clearly negative and diverging from the longer-term trend: the stock is down 2.5% over the past month and -14.3% over three months, versus a +38.4% one-year gain, and the 3-month relative strength of -17.2 points against SPY shows meaningful recent underperformance. The most recent tape is especially weak — the stock fell 4.19% on the latest session (from $59.00 to $56.53) after a brief spike to $63.50 on October 21, suggesting a failed rally attempt and active distribution. This one-month/three-month weakness against a positive one-year trend is a classic deceleration signal: it could reflect profit-taking after the spring surge, but the failure to hold the October bounce raises the probability of a retest of lower support before a durable bottom.
Key technical levels are well defined by the 52-week band: support sits at the $50.65-$51.10 area (the October 7 and September 10 lows) with the ultimate floor at the $39.60 52-week low, while resistance is anchored at the $63.50-$65.00 zone (the recent October spike and prior breakdown shelf) and then the $85.83 52-week high. A decisive break below $50.65 would confirm a lower-high/lower-low structure and open the door toward the $40s, whereas reclaiming $65 would signal the correction has run its course. Volatility is elevated — the -39.7% max drawdown and a short ratio of 4.92 days-to-cover indicate meaningful speculative positioning and two-way risk — so position sizing should assume wider-than-market swings even though a beta figure is not provided in the data set.
Beta
0.75
0.75x market volatility
Max Drawdown
-39.7%
Largest decline past year
52-Week Range
$40-$86
Price range past year
Annual Return
+33.6%
Cumulative gain past year
| Period | COCO Return | S&P 500 |
|---|---|---|
| 1m | -6.5% | -0.2% |
| 3m | -18.9% | +5.5% |
| 6m | -17.0% | +7.1% |
| 1y | +33.6% | +12.3% |
| ytd | +2.4% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COCO Fundamental Analysis
Revenue is reaccelerating sharply: first-quarter 2026 revenue reached $179.8 million, up 37.3% year over year from $130.9 million in Q1 2025, a marked acceleration from the prior quarters' trajectory (Q4 2025 revenue of $127.8 million was roughly flat versus $127.3 million a year earlier, and Q3 2025's $182.3 million compared with $132.9 million in Q3 2024). The segment mix shows Vita Coco Coconut Water at $140.6 million, Private Label at $33.2 million, and Other products at $6.0 million, meaning the branded coconut water line is the dominant growth engine while private label provides a lower-margin volume cushion. The swing from a flat Q4 to a +37% Q1 is the central debate for investors — if it reflects genuine velocity and pricing rather than channel restocking, the growth case is materially stronger than the 2025 trend suggested.
Profitability has improved dramatically: Q1 2026 net income was $30.5 million (a 16.95% net margin) on gross profit of $71.3 million, a 39.68% gross margin, up from $18.9 million of net income and a 36.57% gross margin in Q1 2025 and a 34.54% gross margin in Q4 2025. Operating income of $33.6 million (18.68% operating margin) and EBITDA of $37.9 million (21.09% EBITDA margin) confirm that the margin expansion is flowing through at the operating line, not just gross profit, and the trailing net margin of 11.70% and operating margin of 13.56% understate the current run-rate. For a beverage company, a high-30s gross margin is respectable but not exceptional versus large-cap staples peers, so the story is one of improving mix and operating leverage rather than structural margin superiority.
Financial health is a clear strength: debt-to-equity is just 0.0447, the current ratio is 3.62, and cash at the end of Q1 2026 stood at $203.2 million against negligible debt, giving the company ample internal funding capacity. Free cash flow is lumpy — Q1 2026 FCF was $15.1 million on $15.6 million of operating cash flow, Q4 2025 FCF was -$7.1 million, and trailing free cash flow is $64.5 million — reflecting working-capital swings (a $17.4 million Q1 working-capital drag driven by a $39.4 million receivables build) rather than earnings-quality issues. ROE of 21.5% and ROA of 16.5% are strong for a consumer staples name, and the company is actively returning capital ($11.5 million of buybacks in Q1 2026), underscoring that growth is internally funded.
Quarterly Revenue
$179765000.0B
2026-03
Revenue YoY Growth
+37.3%
YoY Comparison
Gross Margin
39.7%
Latest Quarter
Free Cash Flow
$64523000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COCO Overvalued?
Because net income is positive ($30.5 million in Q1 2026 alone), the PE ratio is the appropriate primary metric: COCO trades at a trailing PE of 42.4x versus a forward PE of 25.0x, a roughly 41% compression that implies the market expects earnings to grow substantially over the next twelve months — consistent with the consensus EPS estimate of $3.09 versus trailing EPS of about $0.024 on a reported basis (the trailing figure is distorted by prior-year weakness). The forward multiple of 25.0x is the more economically meaningful anchor and sits at a premium to the broader consumer staples sector, which typically trades in the high-teens to low-20s, but the gap narrows considerably when measured on forward earnings.
On peer comparison, the stock is expensive across most secondary metrics: PS of 4.95x, EV/Sales of 4.03x, EV/EBITDA of 30.1x, and price-to-book of 9.10x, with a PEG of 1.61x. The EV/EBITDA of 30.1x is a substantial premium to typical beverage-sector multiples in the mid-teens, and the 9.1x book multiple reflects an asset-light model with limited tangible equity rather than overvaluation per se. The premium is defensible only if the 37% revenue growth and ~40% gross margin are sustained — against a sector where mid-single-digit growth is the norm, COCO's growth differential justifies a premium, but the 30x EBITDA multiple leaves little room for execution error.
Historically, COCO's own valuation band has been wide: trailing PE ranged from roughly 20.5x in mid-2024 to 155.6x in Q4 2024 (on depressed earnings), with PS ranging from about 4.7x in mid-2022 to 23.7x in Q4 2025. The current PS of 4.95x is near the low end of its multi-year range, while the forward PE of 25.0x is mid-range versus the 20-25x levels seen in 2024-2025 — suggesting the market is no longer pricing in the euphoric expectations embedded in late-2025 multiples, but is still assigning a growth premium. The combination of a low-end PS and mid-range forward PE implies the recent de-rating has largely normalized valuation, making the stock more sensitive to earnings delivery than to multiple expansion from here.
PE
42.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 15x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
30.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings quality and growth dependence. The Q1 2026 working-capital drag of $17.4M, driven by a $39.4M receivables build, means the headline $15.1M free cash flow was flattered relative to cash conversion, and Q4 2025 FCF was actually -$7.1M. Earnings are highly seasonal and volatile — Q4 2025 net income was $5.5M (4.3% margin) and Q4 2024 was $3.4M (2.7% margin) — so a single weak quarter can gut the trailing earnings base. Revenue is also concentrated: branded coconut water at $140.6M of $179.8M Q1 revenue means the thesis hinges on one product line, while private label ($33.2M) is lower-margin and more price-competitive. The balance sheet itself is a mitigant, with debt-to-equity of 0.0447 and $203.2M cash, so solvency risk is minimal; the risk is multiple compression from a growth stumble, not financial distress.
Market and competitive risks are dominated by valuation. At 30.1x EV/EBITDA, 4.95x PS, and 25.0x forward PE versus staples peers in the high-teens to low-20s, COCO carries a growth premium that requires sustained 20%+ revenue growth to defend. The stock's -39.7% max drawdown and 4.92 short ratio show how violently the market reprices it when confidence wavers, and the 3-month relative strength of -17.2 points against SPY confirms active sector rotation out of the name. Competition is structural: private-label coconut water is a meaningful part of COCO's own mix and a channel for retailers to undercut the branded line, while larger beverage players can enter functional hydration. The provided news flow is thin and not company-specific (a Sysco AI piece), so there is no fresh negative catalyst in the data — but also no positive confirmation beyond the Q1 print.
Worst-case scenario: Q2 2026 reveals that the +37.3% Q1 growth was restocking and pricing, revenue growth decelerates toward the high-teens or below, gross margin slips back from 39.68% toward the 34.5% seen in Q4 2025, and the market re-rates the stock from 30.1x EV/EBITDA toward mid-teens beverage multiples. That combination would take the shares back toward the $50.65-$51.10 October/September support, and a break there opens the path to the $39.60 52-week low — roughly -30% from the current $56.53. Even the analyst low target of $65 implies upside, so the realistic downside is technical rather than fundamental: a -12% to -30% drawdown to $50 or $40, with the -39.7% historical max drawdown as the outer bound if sentiment and fundamentals deteriorate together.
FAQ
Ranked by severity: first, growth durability — the swing from flat Q4 2025 revenue to +37.3% in Q1 2026 could be restocking, and the $39.4M receivables build is a warning sign. Second, valuation compression — at 30.1x EV/EBITDA versus mid-teens beverage peers, any deceleration would hit the multiple hard, as the -39.7% max drawdown demonstrates. Third, margin reversal — gross margin fell to 34.54% in Q4 2025 before rebounding to 39.68%, showing input costs and private-label mix can pressure profitability. Fourth, competitive and concentration risk — branded coconut water is $140.6M of $179.8M Q1 revenue, so share loss to private label or large beverage entrants would hit the core directly. The debt-free balance sheet (0.0447 D/E) mitigates solvency risk, so the primary risk is multiple, not balance sheet.
The 12-month forecast has three scenarios: a base case (50% probability) of $65-$79 as growth moderates to the high-teens/low-20s and the stock grinds toward the $79.10 analyst average; a bull case (25%) of $85-$90 if Q2 confirms 25%+ organic growth with gross margin at or above 40%; and a bear case (25%) of $40-$51 if the Q1 acceleration reverses and the multiple compresses. The base case is most likely, and its key assumption is that gross margin holds in the 37-40% band and forward EPS tracks the $3.09 consensus. The wide $65-$90 analyst target range reflects genuine disagreement about growth durability, so the Q2 print is the pivotal variable.
COCO is fairly valued to modestly undervalued relative to its own history but at a premium to peers. The forward PE of 25.0x is a ~41% discount to the 42.4x trailing multiple, and PS of 4.95x sits near the low end of a multi-year range that peaked around 23.7x in Q4 2025, suggesting the de-rating has largely normalized the stock. However, EV/EBITDA of 30.1x is roughly double typical beverage-sector mid-teens multiples, and P/B of 9.10x reflects an asset-light model with limited tangible equity. The market is pricing in sustained 20%+ growth and gross margin near 40% — a PEG of 1.61x says investors are paying a reasonable but not cheap price for that growth, leaving little room for execution error.
From a risk/reward perspective, COCO offers an asymmetric setup: the analyst average target of $79.10 implies ~40% upside from $56.53, while the realistic downside to the $50.65-$51.10 support is roughly -10% and to the $39.60 52-week low about -30%. The fundamental case is supported by +37.3% Q1 2026 revenue growth, 39.68% gross margin, and a debt-free balance sheet with $203.2M cash. The biggest downside risk is that the Q1 acceleration proves to be restocking rather than durable demand, which would compress the 30.1x EV/EBITDA multiple. It is a good buy for growth-tolerant investors who can stomach a -39.7% historical max drawdown and are willing to scale in rather than chase, particularly on dips toward the low-$50s.
COCO is better suited to a medium-to-long-term holding period of at least 12-24 months rather than short-term trading. The stock's -39.7% max drawdown, 4.92 short ratio, and 38% spread in analyst targets indicate high volatility that makes short-term timing difficult, and the recent failed rally to $63.50 followed by a 4.19% single-session drop shows momentum is unreliable. The company pays no dividend (0% yield, 0% payout), so returns depend entirely on earnings growth and multiple re-rating, which requires patience through quarterly volatility. Earnings visibility is moderate — Q4 quarters have swung between 2.7% and 4.3% net margins — so position sizing should assume wide swings. A staged entry over several months, adding on weakness toward $50-$51 support, fits the risk profile better than a single lump-sum purchase.